The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Primary results from JUPITER, a phase 2 basket trial of combination therapy with trastuzumab and pertuzumab in patients with HER2-amplified solid tumors.
 
Sadakatsu Ikeda
Honoraria - ACT Genomics; AstraZeneca Japan; Bayer; Boehringer Ingelheim; Canon Medical System; Chugai Pharma; Guardant Health; Guardant Health AMEA; IQVIA; Merck; MSD; Novartis; Roche; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Roche
Research Funding - ACT Genomics (Inst); Canon Medical System (Inst); Hitachi (Inst)
Patents, Royalties, Other Intellectual Property - Canon Medical System (Inst); Hitachi (Inst)
Travel, Accommodations, Expenses - Roche
 
Ryo Kudo
No Relationships to Disclose
 
Yamato Yamashita
No Relationships to Disclose
 
Toshio Kubo
No Relationships to Disclose
 
Yukiko Mori
No Relationships to Disclose
 
Yohei Harada
No Relationships to Disclose
 
Hidekazu Shirota
No Relationships to Disclose
 
Hideyuki Hayashi
No Relationships to Disclose
 
Masayuki Kano
No Relationships to Disclose
 
Yasushi Shimizu
No Relationships to Disclose
 
Eri Ishibashi
No Relationships to Disclose
 
Ukihide Tateishi
No Relationships to Disclose
 
Akihiro Hirakawa
No Relationships to Disclose
 
Hirotoshi Akita
No Relationships to Disclose
 
Hisahiro Matsubara
No Relationships to Disclose
 
Hiroshi Nishihara
No Relationships to Disclose
 
Chikashi Ishioka
Honoraria - Asahi Kasei; Chugai Pharma; Daiichi Sankyo; Eisai; Kyowa Kirin International; Lilly Japan; Nihonkayaku; Ono Pharmaceutical; Otsuka; Sanofi; Shionogi; Taiho Pharmaceutical; Takeda; Tsumura & Co.; Yakult Honsha
Research Funding - Asahi Kasei (Inst); Bayer (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Kyowa Hakko Kirin (Inst); Lilly Japan; Nihonkayaku (Inst); Ono Pharmaceutical (Inst); Otsuka; Sanofi; Shionogi; Taiho Pharmaceutical (Inst); Takeda (Inst); Tsumura & Co. (Inst); Yakult Honsha (Inst)
 
Naoko Sueoka-Aragane
No Relationships to Disclose
 
Manabu Muto
Speakers' Bureau - Chugai Pharma
Research Funding - Chugai Pharma; Sysmex; Taiho Pharmaceutical
 
Shinichi Toyooka
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Boehringer Ingelheim; Chugai Pharma; Daiichi Sankyo; Johnson & Johnson; Kyorin; Medtronic; Ono Pharmaceutical; Taiho Pharmaceutical
Speakers' Bureau - Taiho Pharmaceutical
Research Funding - Taiho Pharmaceutical